Dr. Joe Larsen
Dr. Larsen has extensive experience is government program management and is a well-known leader in the field of antibacterial product development. Prior to SMI, Dr. Larsen served as Director of the Division of CBRN Medical Countermeasures within the Biomedical Advanced Research Development Authority (BARDA) where he oversaw a $2.8B fund for the late stage development and procurement of medical products for use during public health emergencies and a $530M annual advanced research and development fund. He was the lead for the BARDA’s work on combating antibiotic resistant bacteria and was an executive member and founder of CARB-X, a novel $450M public private partnership focused on promoting innovation in antibacterial drug development. He served as Chief of the Broad Spectrum Antimicrobials program at BARDA, a portfolio of approximately $1.2B in programs that support the development of novel antibacterial and antiviral drugs. Previously, Dr. Larsen served as a Senior Science and Technology Manager at the Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBDP) within the Defense Threat Reduction Agency (DTRA). Dr. Larsen was an American Association for the Advancement of Science (AAAS) fellow at the Department of Homeland Security. Dr. Larsen received his PhD in Microbiology from the Uniformed Services University of the Health Sciences and his BA with honors from the University of Kansas.